Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 4,240 shares at $1.21 ($5K) on 2020-11-11, disclosed to the SEC on 2020-11-12.
Seasonal purchase ($5k) by Chief Executive Officer — this insider has traded CRBP in November in at least three consecutive prior years. Pattern-driven, low signal.
Something here stands out, but not much.
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |